BUZZ-Metsera bid exit gives boost to Novo Nordisk shares
Reuters
Nov 10, 2025
BUZZ-Metsera bid exit gives boost to Novo Nordisk shares
** Shares in Denmark's Novo Nordisk NOVOb.CO rise around 3% after it dropped its bid for obesity drug developer Metsera MTSR.O
** Metsera accepted the offer from Pfizer PFE.N late on Friday, while Novo said on Saturday it would not be making an increased offer and said it would exit the race
** "Metsera is out of sight for investors, and it sounds more negative than it probably is," Nordnet analyst Per Hansen says
(Reporting by Elviira Luoma)
((Elviira.luoma@thosmonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.